Haemonetics' net profit under GAAP for the 3 months of fiscal 2021 was $10,527 million compared to a loss of $8,479 million in the prior year. Revenues decreased by 18% to $195,577 million compared to $238,451 million a year earlier.
Haemonetics' net profit under GAAP for the 3 months of fiscal 2021 was $10,527 million compared to a loss of $8,479 million in the prior year. Revenues decreased by 18% to $195,577 million compared to $238,451 million a year earlier. 
English (US) 